Cancellation of state registration. Cefotaxim Sandoz®

February 10, 2017

Active substances:

Cefotaxime

Trade names:

Cefotaxim Sandoz®

ICD-10:

I.A00-A09.A02 Other salmonella infections

I.A30-A49.A40 Streptococcal septicemia

I.A30-A49.A41 Other septicemia

I.A50-A64.A54 Gonococcal infection

I.A50-A64.A56.0 Chlamydial infections of the lower parts of the genito-urinary tract

I.A50-A64.A56.1 Chlamydial infections of the pelvic organs and other urogenital organs

I.A50-A64.A56.4 Chlamydial pharyngitis

I.A65-A69.A69.2 Lyme disease

VI.G00-G09.G00 Bacterial meningitis, not elsewhere classified

IX.I30-I52.I33 Acute and subacute endocarditis

X.J00-J06.J01 Acute Sinusitis

X.J00-J06.J02 Acute pharyngitis

X.J00-J06.J03 Acute tonsillitis

X.J00-J06.J04 Acute laryngitis and tracheitis

X.J10-J18.J15 Bacterial pneumonia, not elsewhere classified

X.J20-J22.J20 Acute bronchitis

X.J30-J39.J31 Chronic rhinitis, nasopharyngitis and pharyngitis

X.J30-J39.J32 Chronic Sinusitis

X.J30-J39.J35.0 Chronic tonsillitis

X.J30-J39.J37 Chronic laryngitis and laryngotracheitis

X.J40-J47.J42 Chronic bronchitis, unspecified

XI.K65-K67.K65.0 Acute peritonitis

XI.K80-K87.K81.0 Acute cholecystitis

XI.K80-K87.K81.1 Chronic cholecystitis

XI.K80-K87.K83.0 Cholangitis

XII.L00-L08.L01 Impetigo

XII.L00-L08.L02 Abscess of skin, boil and carbuncle

XII.L00-L08.L03 Phlegmon

XII.L00-L08.L08.0 Pyoderma

XIII.M00-M03.M00 Pyogenic arthritis

XIII.M86-M90.M86 Osteomyelitis

XIV.N10-N16.N11 Chronic tubulointerstitial nephritis

XIV.N10-N16.N10 Acute tubulointerstitial nephritis

XIV.N30-N39.N30 Cystitis

XIV.N30-N39.N34 Urethritis and urethral syndrome

XIV.N40-N51.N41 Inflammatory diseases of the prostate

XIV.N70-N77.N70 Salpingitis and oophoritis

XIV.N70-N77.N72 Inflammatory disease of the cervix

XIV.N70-N77.N71.9 Inflammatory disease of uterus, unspecified

XIV.N70-N77.N73.0 Acute parametritis and pelvic cellulite

XIX.T79.T79.3 Post-traumatic wound infection, not elsewhere classified

XXI.Z20-Z29.Z29.2 Another type of preventive chemotherapy

Cefotaxime, bacterial infections of severe course, meningitis, peritonitis, sepsis, pneumonia, inflammatory skin diseases, phlegmon, abscess, pyelonephritis, infection against immunodeficiency, osteomyelitis

The Ministry of Health of the Russian Federation in accordance with Article 32 of Federal Law No. 61-FZ of 12.04.2010 "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate LSR-007706 / 08 dated September 25, 2008 issued by Sandoz GmbH, Austria):

Cefotaxim Sandoz® (trade name of the medicinal product)

Cefotaxime (international non-proprietary or grouping or chemical name)

powder for solution for intravenous and intramuscular injection, 0.5 g, 1.0 g (dosage form, dosage)

Sandoz GmbH, Austria Biochemiestrasse 10, A-6250 Kundl, Austria (name and address of the location of the manufacturer of the medicinal product)

on the basis of the application of CJSC "Sandoz" application for a medicinal product.